-
¹ØÓÚjs3333Ïß·¼ì²âÖÐÐÄ
-
´´ÐÂÓë¹ú¼Ê»¯
-
js3333Ïß·¼ì²âÖÐÐĶ¯Ì¬
-
-
¿É³ÖÐø·¢Õ¹
-
-
-
У԰ÕÐƸ
-
ʵϰÉúÕÐƸ
-
ÍâÑóÈ˲ÅÕÐƸ
²ÎÓëjs3333Ïß·¼ì²âÖÐÐÄ
-
-
ÆóÒµ·¢Õ¹¶¯Ì¬×îÇ°ÑØ£¬£¬ºëÑïjs3333Ïß·¼ì²âÖÐÐÄÕýÄÜÁ¿
·ï»ËÍøعú²úÐÂÒ»´úALK¿ËÖƼÁ¡ª¡ªjs3333Ïß·¼ì²âÖÐÐÄÒÁ³°¢¿ËÁÙ´²Êý¾Ý¹ú¼Ê³õ´Î°ä²¼
ABOUT US
·ï»ËÍøعú²úÐÂÒ»´úALK¿ËÖƼÁ¡ª¡ªjs3333Ïß·¼ì²âÖÐÐÄÒÁ³°¢¿ËÁÙ´²Êý¾Ý¹ú¼Ê³õ´Î°ä²¼
°ä²¼¹¦·ò£º£º
2022-02-26
½üÈÕ£¬£¬ÓɳÛÃû·Î°©×¨¼Ò¡¢¡¢Öйúҽѧ¿ÆѧԺÖ×ÁöҽԺʯԶ¿½ÌÊÚÖ÷µ¼µÄ¹ú²ú´´ÐÂÒ©ÎïÒÁ³°¢¿ËIÆÚÁÙ´²×êÑÐÁ˾ÖSafety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial ÕýʽÔÚÆÚ¿¯Signal Transduction and Targeted Therapy£¨¡¶ÐźÅתµ¼ºÍ°ÐÏòÒ½ÖΡ·£©È«ÎÄ°ä·¢¡£¡£
ÒÁ³°¢¿ËƬÊÇÓÉjs3333Ïß·¼ì²âÖÐÐÄ×ÔÖ÷Ñз¢µÄÐÂÐÍALK/ROS1¿ËÖƼÁ£¬£¬¿É¿ËÖÆ·ÖÆçÈÚºÏÀàÐ͵ÄÒ°ÉúÐÍÒÔ¼°ALK¿ËÖƼÁÄÍÒ©Í»±äµÄALK¼¤Ã¸»îÐÔ£¬£¬Í¬Ê±¿ÉÓÐЧ¿ËÖÆ·ÖÆçÈÚºÏÀàÐÍROS1¼¤Ã¸µÄ»îÐÔ¡£¡£
ÎÄÕÂϵͳ½éÉÜÁËÒÁ³°¢¿ËÔÚ¢ñÆÚ¼ÁÁ¿µÝÔö¼°ÈËȺÀ©´ó½×¶ÎÖа²È«ÐÔ¡¢¡¢ÄÍÊÜÐÔ¼°³õ²½ÁÆЧµÈµÄÈ«Ãæ·ÖÎö¡£¡£¼ÁÁ¿µÝÔö½×¶ÎµÄÖØÒªÖÕµãÖ¸±êΪ×î´óÄÍÊܼÁÁ¿£¨MTD£©£¬£¬¼ÁÁ¿ÏÞ¶ÈÐÔ¶¾ÐÔ£¨DLT£©ºÍ°²È«ÐÔ£¬£¬ÈËȺÀ©´ó½×¶ÎµÄÖØÒªÖÕµãÖ¸±êΪ×êÑÐÕßÆÀ¹ÀµÄ¿Í¹Û»º½âÂÊ£¨ORR£©¡£¡£×Ô2017Äê9ÔÂ25ÈÕÖÁ2018Äê10ÔÂ15ÈÕ£¬£¬µÝÔö½×¶Î¹²Èë×é54ÀýALK/ROS1+ NSCLC»¼Õߣ¬£¬À©´ó½×¶Î¹²Èë×é99ÀýALK/ROS1+ NSCLC»¼Õߣ¬£¬¹²¼Æ153Àý»¼Õß½ÓÊÜÁËÒÁ³°¢¿ËƬҽÖΣ¬£¬±¾×êÑÐδ»ñµÃMTD¡£¡£µÝÔö½×¶ÎºÍÀ©´ó½×¶ÎµÄÕûÌåORR±ðÀëΪ59.3% (32/54)ºÍ56.6% (56/99)¡£¡£ÆäÖУ¬£¬Î´½ÓÊܹýALK¿ËÖƼÁÒ½ÖεÄALK+NSCLC»¼ÕßÖУ¬£¬Á½½×¶ÎµÄORR±ðÀëΪ81.0% (17/21) ºÍ76.3% (29/38)£»£»£»¼ÈÍù½ÓÊܹý¿ËßòÌæÄáÒ½ÖεÄALK+NSCLC»¼ÕßÖУ¬£¬Á½½×¶ÎµÄORR±ðÀëΪ38.1% (8/21) ºÍ 45.7% (21/46)¡£¡£ÔÚROS1+NSCLC»¼ÕßÖУ¬£¬µÝÔöºÍÀ©´ó½×¶ÎµÄORR±ðÀëΪ30.0% (3/10)ºÍ44.4% (4/9)¡£¡£ÒÔÉÏÊý¾ÝÏÔʾ£¬£¬ÒÁ³°¢¿ËÔÚALK/ROS1+ NSCLC»¼ÕßÖÐÓµÓÐÓÅÁ¼µÄ°²È«ÐÔ¡¢¡¢ÄÍÊÜÐԺͿ¹Ö×Áö»îÐÔ¡£¡££¨µÝÔöºÍÀ©´ó½×¶ÎÖл¼ÕßÖ×ÁöÏà¶Ô»ùÏ߱䶯µÄ×î´ó°Ù·Ö±È¼ûͼaºÍͼb£©
·Î°©ÊÇÄ¿Ç°È«Çò×î³£¼ûµÄ¶ñÐÔÖ×Áö£¬£¬Ò²ÊǶñÐÔÖ×ÁöéæÃüµÄÊ×λÔÒò£¬£¬Ô¼Õ¼ËùÓжñÐÔÖ×ÁöéæÃüµÄ18%¡£¡£ÎÒ¹ú·Î°©µÄ·¢²¡Âʼ°éæÃüÂÊÔö³¤Ñ¸ËÙ£¬£¬ÒѳÉΪÎÒ¹ú¶ñÐÔÖ×Áö·¢²¡ºÍéæÃüµÄÊ×λÔÒò¡£¡£·ÇСϸ°û·Î°©£¨NSCLC£©ÊǷΰ©ÖÐ×î³£¼ûµÄ²¡Àí×é֯ѧÀàÐÍ£¬£¬Ô¼Õ¼·Î°©µÄ85£¥£¬£¬ÆäÔçÆÚÕï¶ÏÄÑ»¼ÕßÔ¤ºó²î£¬£¬ÍùÍùÒѾȷÕï¾ÍÒѾ´¦ÓÚÍíÆÚ£¬£¬ÊǷΰ©»¼ÕßÖÂËÀÂʸߵÄÖØÒªÔÒò¡£¡£
½üÄêÀ´£¬£¬ÍíÆÚ·ÇСϸ°û·Î°©ÔÚÒ½Öη½Ãæ³öÏÖÖØ´óµÄģʽת±ä¡£¡£¹Ø¼üÖ°©ÐÔÍ»±ä£¨ÈçÇý¶¯»ùÒòÍ»±äºÍȾɫÌåÖØÅÅ£©µÄ·¢ÏÖ£¬£¬Ê¹µÃ°ÐÏòÒ½ÖÎÏà±È´«Í³µÄϸ°û¶¾ÐÔ»¯Ñ§ÁÆ·¨ÏÔʾ³ö¸ü¸ßµÄÃô¸ÐÐÔ¡£¡£¼ä±äÐÔÁÜ°ÍÁö¼¤Ã¸£¨ALK£©»ùÒòÍ»±äÓÉÓÚ²úÉúÂʵͣ¬£¬µ«¶Ô°ÐÏòÒ½ÖÎÃô¸ÐÐԺ㬣¬Éú¼Æ¹¦·ò³¤±»³ÆΪ·Î°©µÄ“×êʯͻ±ä”¡£¡ £¿£¿ËßòÌæÄáÊǵÚÒ»´úÕë¶ÔALK+NSCLCµÄ°ÐÏòÒ©ÎALK-TKI£©£¬£¬Ö»¹Ü»¼Õ߶ԿËßòÌæÄáµÄÒ½ÖÎÓÐÓÅÁ¼µÄ·´Ó³£¬£¬µ«´óÎÞÊý»¼Õß×îÖÕ»á²úÉúÄÍÒ©£¬£¬Ô̺¬Ô·¢ÄÍÒ©ºÍ¼Ì·¢ÄÍÒ©£¬£¬²¢ÇÒ¿ËßòÌæÄá¶Ô¹é²¢ÄÔתÒÆÕßµÄÁÆЧ²»¾¡ÈçÈËÒâ¡£¡£°¢À´ÌæÄá×÷ΪµÚ¶þ´úALK-TKIµÄ´ú±í¹ÌÈ»±»Ö¤Ã÷ÓµÓи߶ÈÑ¡ÔñÐÔºÍÂÄÚ²¡Ôî½ÚÖÆÂÊ£¬£¬µ«ÏÕЩËùÓеĻ¼ÕßÒ²»áÔٴνøչΪTKIÄÍÒ©£¬£¬Òò¶øALK+NSCLC»¼ÕßÒÀÈ»´æÔڽϴóδ±»Âú×ãµÄÒ½ÖÎÐèÒª¡£¡£
ÕýÊÇÔÚÕâÒ»²¼¾°Ï£¬£¬js3333Ïß·¼ì²âÖÐÐÄ»ý¼«²¼¾Ö£¬£¬Ö´ÐÐÁËÒ»Àà´´ÐÂÒ©ÎïÒÁ³°¢¿ËÑз¢ÏîÄ¿¡£¡£ÓÚ2016Äê5Ô³õ´ÎÉ걨ÁÙ´²£¬£¬2017Äê10Ô³õ´Î¹«Ê¾Æô¶¯ÁÙ´²£¬£¬NDAÒÑÓÚ2021Äê7ÔÂÌá½»ÖÁCDE²¢»ñµÃÊÜÀí¡£¡£
¾ÝϤ£¬£¬js3333Ïß·¼ì²âÖÐÐı¾´ÎÉêÇëÉÏÊеÄÊÊӦ֢Ϊ“ºÏÓÃÓÚ¼ÈÍù½ÓÊܹý¿ËßòÌæÄáÒ½Öκ󼲲¡½øÕ¹»ò¶Ô¿ËßòÌæÄá²»ÄÍÊܵļä±äÐÔÁÜ°ÍÁö¼¤Ã¸£¨ALK£©ÑôÐԵIJ¿ÃÅÍíÆÚ»òתÒÆÐÔ·ÇСϸ°û·Î°©£¨NSCLC£©»¼ÕßµÄÒ½ÖΔ£¬£¬Êý¾ÝÆðÔ´ÓÚÒ»Ïîµ¥±Û¡¢¡¢¢òÆÚÁÙ´²×êÑС£¡£
²úÆ·ÓÐÍûÓÚ½ñÄêÏ°ëÄêÔÚ¹úÄÚÉÏÊУ¬£¬ÎªÖйúÍíÆÚALKÑôÐÔ·ÇСϸ°û·Î°©»¼ÕßÌṩеÄÒ½ÖÎÑ¡Ôñ¡£¡£
ÓйØÐÂÎÅ
лªÍøØjs3333Ïß·¼ì²âÖÐÐÄ°¬ÅÁÂåÀûÍÐÎÖÈðÀûµ¥¿¹×¢ÉäÒºÐÂÊÊÓ¦Ö¢ÉÏÊÐÉêÇë»ñCDEÊÜÀí
2026-05-04
0531-83126666 
wangzhan@qilu-pharma.com 
µç»°£º£º0531-83126666 / 7777 / 8888 / 9999
Ò©Îï½è¼ø¿Í·þÈÈÏߣº£º400-127-7799
´«Õ棺£º0531-83126688 / 9688
µØÖ·£º£ºÉ½¶«Ê¡³à·åÊиßÐÂÇøÓÎÀÀ·8888ºÅ
ÓÊÏ䣺£ºwangzhan@qilu-pharma.com
¹©¸øÉÌÖÎÀíÈËÔ±
Âú³¬ ¼¯ÍŹ©¸øÉÌÖÎÀíÕƹÜÈË 0531-83129027
À óÒ×»¯´ó³ö²úÓô¦£º£º»¯¹¤ÖÐÑëÌ壨¹ÌÌ壩 0531-83126624
ÕÅê»î£ óÒ×»¯´ó³ö²úÓô¦£º£º»¯¹¤ÈÜý£¨ÒºÌ壩 0531-55820677
¾®Î¬ÖÞ ÖƼÁÓô¦£º£ºÊÞÒ©ÔÁÏÒ©¡¢¡¢ÊÞÒ©¸¨ÁÏ£»£»£»´ó·¢½ÍÀàÔÁÏ 0531-55820837
ÐÏÓ¯ ÖƼÁÓô¦£º£º°ü²Ä¡¢¡¢ÈËÒ©ÔÁÏÒ©¡¢¡¢ÈËÒ©Ò©Óø¨ÁÏ 0531-55820612
Àî½ð»¨ Ñз¢Óô¦£º£º»ñÅúÇ°ÕØʼÎïÁÏ/ÖÐÑëÌ壨¹ÌÌ壩¡¢¡¢ÔÓÖÊ¡¢¡¢³ß¶ÈÆ·¡¢¡¢²Î±ÈÖƼÁ
0531-55820602
ÀîÕñ½ ϸ°û¡¢¡¢Ôì¾Í»ù¡¢¡¢³¢ÊÔÊÒ¼ì²âÓÃÊÔ¼Á¡¢¡¢ÌîÁÏ¡¢¡¢Ïû¶¾¼Á¡¢¡¢»·¾³¼ì²âÓÃÊÔ¼Á¡¢¡¢³¢ÊÔÊÒºÄ
²Ä¡¢¡¢É«Æ׺IJġ¢¡¢ÉúÎïÒ©³ö²úÓÃÒ»´ÎÐԺIJġ¢¡¢ÎÞ¾úÊÒÓÃºÄ²Ä 0531-55820848
Ì·ºìÑÒ ÐÅÏ¢»¯ÏµÍ³£¨IT»ù´¡Èí¼þµÈ£©¡¢¡¢·þÎñ£¨Èý·½Êý¾Ý¿â¡¢¡¢×¨ÒµÈí¼þµÈ£©¡¢¡¢ITÏîÄ¿£¨»ù
´¡ÉèÊ©¡¢¡¢ÀûÓÃϵͳµÈ¡¢¡¢MRO 0531-83129023
Õźé·å É豸ÒÇÆ÷¡¢¡¢±¸Æ·±¸¼þ¡¢¡¢MRO£¨Îå½ð°Ù»õ£© 0531-83129021
·½Á¢ ÉÌÂᢡ¢ÎïÁ÷¡¢¡¢Ò½Ñ§·þÎñ¡¢¡¢Ê³²Ä 0531-55820861
Áõ´«¸» »áÒé·þÎñ¡¢¡¢ÉÌÎñÓÃÆ·¡¢¡¢µçÉÌ 0531-55821862
ÑîÐñ¹â ¹©¸øÉÌÆÀ¼Û¡¢¡¢¹©¸øÉÌÐÅÏ¢µ÷»»¶Ô½Ó¡¢¡¢¹©¸øÉ̲éºË¡¢¡¢Ë÷Åâ¡¢¡¢Ô¼Ì¸¡¢¡¢Í˳ö¡¢¡¢¹©¸øÉÌÉó¼Æе÷¹µÍ¨¡¢¡¢ÖÊÁ¿Òì³£´¦Öᢡ¢²»Á¼Í¶Ëß½Ó¹Ü 0531-55820852
¼à¶½¾Ù±¨
ÐÄ°®µÄºÏ×÷ͬ°é£º£º
»¶Ó¾Ù±¨ÒÔÏÂÐÐΪ£¡£¡£¡
Ë÷»ß¡¢¡¢°µÏä°Ñ³ÖÕбꡢ¡¢ÄÚ¶¨Öб굥Ԫ¡¢¡¢Ô±¹¤»òÇ×Êô²Î¼Ó¹«Ë¾ÒµÎñÍùÀ´Ä²È¡Ë½Àû¡¢¡¢Íµ¹¤¼õÁÏ¡¢¡¢ÒԴγäºÃ¡¢¡¢ÓÐÒâµóÄѹ©¸øÉ̵ÈÐÐΪ¡£¡£
¾Ù±¨µç»°£º£º0531-83126898/55820713/83126871
¾Ù±¨ÓÊÏ䣺£ºqljc@qilu-pharma.com
ÊÕÐŵØÖ·£º£ºÉ½¶«Ê¡³à·åÊÐÀú³ÇÇøÓÎÀÀ·8888ºÅ
js3333Ïß·¼ì²âÖÐÐļ¯ÍÅÉó¼Æ¼à²ì²¿
²É¹ºÆ½Ì¨¼¼ÊõרÏß